| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Susan Costantini | Q30512272 |
| Stefania Scala | Q38545851 | ||
| Giuseppe Castello | Q43115591 | ||
| P2860 | cites work | Cancer Epidemiology, Biomarkers & Prevention | Q326334 |
| Suppressive effect of Siraitia grosvenorii extract on dicyclanil-promoted hepatocellular proliferative lesions in male mice | Q46139068 | ||
| Black tea polyphenols modulate xenobiotic-metabolizing enzymes, oxidative stress and adduct formation in a rat hepatocarcinogenesis model | Q46263761 | ||
| Antiproliferative potential of gallic acid against diethylnitrosamine-induced rat hepatocellular carcinoma | Q46482187 | ||
| Serum cytokine levels in patients with hepatocellular carcinoma | Q46745912 | ||
| Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms | Q24648759 | ||
| T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. | Q27469830 | ||
| Broad Specificity of Virus-Specific CD4+ T-Helper-Cell Responses in Resolved Hepatitis C Virus Infection | Q27472915 | ||
| Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease | Q27473001 | ||
| Toll-like receptors regulation of viral infection and disease☆ | Q27486231 | ||
| Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon | Q27487518 | ||
| Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence | Q27488844 | ||
| Zhonghua yi xue za zhi | Q27710254 | ||
| Analysis of successful immune responses in persons infected with hepatitis C virus | Q27860698 | ||
| Determinants of viral clearance and persistence during acute hepatitis C virus infection | Q28131757 | ||
| Hepatocellular carcinoma: epidemiology and molecular carcinogenesis | Q28306363 | ||
| Health effects of quercetin: From antioxidant to nutraceutical | Q28747107 | ||
| Cancer statistics, 2007 | Q29547293 | ||
| Evasion of intracellular host defence by hepatitis C virus | Q29618976 | ||
| Adaptive immune responses in acute and chronic hepatitis C virus infection | Q29619722 | ||
| Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C | Q29620614 | ||
| 1 alpha,25-Dihydroxyvitamin D(3) inhibits rat liver ultrastructural changes in diethylnitrosamine-initiated and phenobarbital promoted rat hepatocarcinogenesis | Q32162912 | ||
| Oxidative damage to DNA: relation to species metabolic rate and life span | Q33567378 | ||
| Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection. | Q33841892 | ||
| Regulation and antimetastatic functions of liver-associated natural killer cells | Q33916578 | ||
| Increased lipid peroxidation in patients with non-alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane. | Q51910766 | ||
| A long-term glycyrrhizin injection therapy reduces hepatocellular carcinogenesis rate in patients with interferon-resistant active chronic hepatitis C: a cohort study of 1249 patients. | Q53347425 | ||
| Selenium prevents tumor development in a rat model for chemical carcinogenesis. | Q53364455 | ||
| Chemoprevention of aflatoxin B1-initiated and carbon tetrachloride-promoted hepatocarcinogenesis in the rat by green tea. | Q53396116 | ||
| Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis. | Q53414005 | ||
| Epidemiology of viral hepatitis infections in an area of southern Italy with high incidence rates of liver cancer | Q56336688 | ||
| Resident human hepatitis lymphocytes are phenotypically different from circulating lymphocytes | Q58143640 | ||
| Prediagnostic Level of Serum Retinol in Relation to Reduced Risk of Hepatocellular Carcinoma | Q59099512 | ||
| Chemoprevention trial of human hepatitis with selenium supplementation in China | Q69136812 | ||
| Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group | Q71073938 | ||
| AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet | Q72577338 | ||
| Successful interferon therapy reverses enhanced hepatic iron accumulation and lipid peroxidation in chronic hepatitis C | Q73674286 | ||
| Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma | Q77215000 | ||
| Levels of transforming growth factor beta and transforming growth factor beta receptors in rat liver during growth, regression by apoptosis and neoplasia | Q77220651 | ||
| Serum levels of cytokines in hepatitis C-related liver disease: a longitudinal study | Q77946479 | ||
| Hepatitis C and hepatocellular carcinoma | Q84747977 | ||
| Hepatocellular carcinoma in patients with chronic hepatitis C virus infection without cirrhosis | Q34084962 | ||
| Use of yttrium-90 microspheres in patients with advanced hepatocellular carcinoma and portal vein thrombosis | Q34155198 | ||
| Immunology of the healthy liver: old questions and new insights | Q34157060 | ||
| Noncytolytic control of viral infections by the innate and adaptive immune response | Q34178107 | ||
| Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults | Q34532749 | ||
| Viral hepatitis and liver cancer: the case of hepatitis C. | Q34568619 | ||
| Meta-analysis: interferon-alpha prevents the recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma | Q34611545 | ||
| Rationale and feasibility of chemoprovention of hepatocellular carcinoma by cyclooxygenase-2 inhibitors | Q34650351 | ||
| Proteomic profiling of human liver biopsies: hepatitis C virus-induced fibrosis and mitochondrial dysfunction | Q34656176 | ||
| Radical causes of cancer. | Q35097371 | ||
| Study on chemoprevention of hepatocellular carcinoma by ginseng: an introduction to the protocol | Q35451041 | ||
| Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis | Q35882733 | ||
| Innate immunity in the liver | Q36036373 | ||
| Innate immune responses to infection | Q36219981 | ||
| HBV induced carcinogenesis | Q36388400 | ||
| Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress | Q36444952 | ||
| The role of cytokines in hepatocellular carcinoma | Q36583165 | ||
| Liver immunity and tumour surveillance | Q36652352 | ||
| Redox regulation of hepatitis C in nonalcoholic and alcoholic liver | Q36909902 | ||
| Chronic inflammation and oxidative stress in human carcinogenesis | Q36950970 | ||
| Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma. | Q37028389 | ||
| Vegetable, fruit and antioxidant nutrient consumption and subsequent risk of hepatocellular carcinoma: a prospective cohort study in Japan | Q37080894 | ||
| Resveratrol: one molecule, many targets | Q37141875 | ||
| Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. | Q37157400 | ||
| Phytochemicals as potential chemopreventive and chemotherapeutic agents in hepatocarcinogenesis | Q37348969 | ||
| Mechanisms of HCV survival in the host | Q37433774 | ||
| Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2. | Q37438352 | ||
| Prevention of hepatocellular carcinoma complicating chronic hepatitis C. | Q37445121 | ||
| Characterization of the cellular immune response in hepatitis C virus infection | Q37451105 | ||
| Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma | Q37632027 | ||
| HCV-related hepatocellular carcinoma: From chronic inflammation to cancer | Q37632065 | ||
| Dietary antioxidants in the prevention of hepatocarcinogenesis: a review. | Q37761684 | ||
| IL28B in hepatitis C virus infection: translating pharmacogenomics into clinical practice. | Q37773168 | ||
| Acyclic retinoid synergises with valproic acid to inhibit growth in human hepatocellular carcinoma cells | Q39839163 | ||
| Does chemotherapy prevent HCV-related hepatocellular carcinoma? Cons | Q39860917 | ||
| Inhibitory effects of xanthohumol from hops (Humulus lupulus L.) on human hepatocellular carcinoma cell lines | Q39936338 | ||
| Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: an analysis based on gender differences | Q39964655 | ||
| Synergistic growth inhibition by 9-cis-retinoic acid plus trastuzumab in human hepatocellular carcinoma cells | Q39986318 | ||
| Hepatitis C virus core protein inhibits deoxycholic acid-mediated apoptosis despite generating mitochondrial reactive oxygen species | Q40280016 | ||
| Modulation of the transforming growth factor-beta signal transduction pathway by hepatitis C virus nonstructural 5A protein | Q40331093 | ||
| Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma | Q40436418 | ||
| Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells. | Q40533079 | ||
| Role of free radicals in liver diseases. | Q41983643 | ||
| Chemoprevention by S-adenosyl-L-methionine of rat liver carcinogenesis initiated by 1,2-dimethylhydrazine and promoted by orotic acid | Q42489252 | ||
| Interferon reduces the risk of hepatocellular carcinoma in hepatitis C virus-related chronic hepatitis/liver cirrhosis | Q42975619 | ||
| Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection | Q42981653 | ||
| Hepatitis C virus induces oxidative stress, DNA damage and modulates the DNA repair enzyme NEIL1. | Q42994110 | ||
| Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis. | Q42997546 | ||
| Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. | Q42998720 | ||
| Predictive power of biomarkers of oxidative stress and inflammation in patients with hepatitis C virus-associated hepatocellular carcinoma | Q43034794 | ||
| Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs | Q43036841 | ||
| Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection | Q43041922 | ||
| Eradication of hepatitis C virus RNA after alpha-interferon therapy | Q43042415 | ||
| Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. | Q43048494 | ||
| Efficacy of lanreotide in preventing the occurrence of chemically induced hepatocellular carcinoma in rats | Q43252513 | ||
| An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. | Q43636357 | ||
| Preventive effect of FK143, a 5alpha-reductase inhibitor, on chemical hepatocarcinogenesis in rats. | Q43670914 | ||
| Immunohistochemical evaluation of oxidative stress markers in chronic hepatitis C. | Q43752990 | ||
| Effect of alpha-tocopherol on hepatocarcinogenesis in transforming growth factor-alpha (TGF-alpha) transgenic mice treated with diethylnitrosamine | Q43810497 | ||
| Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004. | Q43905234 | ||
| A population-based follow-up study on mortality from cancer or cardiovascular disease and serum carotenoids, retinol and tocopherols in Japanese inhabitants | Q44087231 | ||
| Vegetable consumption, serum retinol level, and risk of hepatocellular carcinoma. | Q44327771 | ||
| Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene. | Q44482357 | ||
| Innate immunity in hepatitis C virus infection: Interplay among dendritic cells, natural killer cells and natural killer T cells | Q45399738 | ||
| Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection | Q45737458 | ||
| Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong | Q45762995 | ||
| Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis | Q45876518 | ||
| Potential chemoprevention of N-nitrosodiethylamine-induced hepatocarcinogenesis by polyphenolics from Acacia nilotica bark. | Q46009500 | ||
| Chemoprevention of rat hepatocarcinogenesis with histone deacetylase inhibitors: efficacy of tributyrin, a butyric acid prodrug. | Q46132555 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatitis C | Q154869 |
| hepatocellular carcinoma | Q1148337 | ||
| liver neoplasm | Q18558073 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 109 | |
| P577 | publication date | 2010-11-03 | |
| P1433 | published in | Journal of Translational Medicine | Q15716664 |
| P1476 | title | Targeting the inflammation in HCV-associated hepatocellular carcinoma: a role in the prevention and treatment | |
| P478 | volume | 8 |
| Q60947283 | Bicyclol Attenuates Liver Inflammation Induced by Infection of Hepatitis C Virus Repressing ROS-Mediated Activation of MAPK/NF-κB Signaling Pathway |
| Q38157936 | Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations |
| Q28480545 | Cytokinome profile of patients with type 2 diabetes and/or chronic hepatitis C infection |
| Q43039948 | Gene expression patterns in livers of Hispanic patients infected with hepatitis C virus |
| Q38952176 | In one harness: the interplay of cellular responses and subsequent cell fate after quantum dot uptake |
| Q35268414 | Influence of viral hepatitis status on prognosis in patients undergoing hepatic resection for hepatocellular carcinoma: a meta-analysis of observational studies |
| Q38235254 | Insights on the CXCL12-CXCR4 axis in hepatocellular carcinoma carcinogenesis |
| Q40599990 | Mycotoxin Patulin Suppresses Innate Immune Responses by Mitochondrial Dysfunction and p62/Sequestosome-1-dependent Mitophagy |
| Q36961950 | Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients |
| Q35077721 | TP53 and MDM2 gene polymorphisms, gene-gene interaction, and hepatocellular carcinoma risk: evidence from an updated meta-analysis |
| Q35857515 | The prevention of infection-associated cancers |
| Q35863880 | Transarterial chemoembolization plus sorafenib: a sequential therapeutic scheme for HCV-related intermediate-stage hepatocellular carcinoma: a randomized clinical trial. |
| Q92753657 | Tumor-Infiltrating Leukocyte Composition and Prognostic Power in Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas |
Search more.